跳至主要内容
临床试验/NCT02137330
NCT02137330已完成3 期

Tolerance and Efficacy of the Swallowable Obalon® Gastric Balloons System in Children With Severe Obesity

Bambino Gesù Hospital and Research Institute2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2014年1月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
10
试验地点
2
主要终点
Weight loss (Kg)

研究概览

简要总结

The ongoing global rise in the prevalence of overweight and obesity among all ages and among all ethnic groups, figures into a real epidemic phenomenon. This is accompanied by a higher incidence in serious health risks, already present at an early age, "switching-on" the engine towards obesity-related co-morbid diseases and morbid obesity. Weight loss is the only way to avoid systemic and cardiovascular complications of obesity.

Weight loss devices have been recently introduced in bariatric surgery, also in children. They mostly require invasive procedures to be applied. Mini-invasive devices would be needed to obtain weight loss in the pediatric population, since the early age of involved patients.

Obalon intragastric balloons, are swallowable devices. They are filled with liquid or air, and have been used to induce weight loss in obese adults. The investigators aimed to perform a pilot study in pediatrics, and monitor weight loss, metabolic and cardiovascular parameters modifications, after up-to-3 Obalon® Gastric Balloons placement.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
9 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Weight > 97° pc -CDC BMI charts-

排除标准

  • Prevous abdominal surgery
  • Functional gastrointestinal motility disorders

结局指标

主要结局

Weight loss (Kg)

时间窗: 3 months

次要结局

  • Number of Participants with Adverse Events as a Measure of Safety and Tolerability(3 months)

研究者

发起方
Bambino Gesù Hospital and Research Institute
申办方类型
Other
责任方
Principal Investigator
主要研究者

Valerio Nobili

MD

Bambino Gesù Hospital and Research Institute

研究点 (2)

Loading locations...

相似试验